Urogen Pharma Ltd.

URGN·NASDAQ·$29.46Share Price as of 11/2·$1BMarket Cap as of 11/2

Financials

10-QQ2 ended 06/30/2608/05/26 10-QQ1 ended 03/31/2605/06/26 10-KFY 202503/02/26 10-QQ3 ended 09/30/2511/06/25 10-QQ2 ended 06/30/2508/07/25

Disclosures

8-KCurrent report08/20/26 8-KCurrent report08/05/26 8-KCurrent report06/23/26 8-KCurrent report06/02/26 8-KCurrent report05/06/26

Prospectuses and Registrations

S-3ASRAutomatic shelf registration11/06/25 S-8Registration of securities for employees11/06/25 S-8Registration of securities for employees08/13/24 424B5Prospectus supplement06/18/24 424B5Prospectus supplement06/17/24

Proxies

DEF 14ADefinitive proxy04/30/26 PRE 14APreliminary proxy04/17/26 DEF 14ADefinitive proxy07/15/25 DEF 14ADefinitive proxy07/01/24 DEFA14AAdditional proxy materials07/01/24

Ownership

144Proposed sale of securities10/09/26 Form 4Insider transaction10/09/26 144Proposed sale of securities09/09/26 144Proposed sale of securities09/09/26 Form 4Insider transaction09/09/26

Other

ARSAnnual report to shareholders05/27/26 ARSAnnual report to shareholders07/16/25 ARSAnnual report to shareholders07/09/24 UPLOADLetter from the SEC12/05/23 CORRESPCorrespondence with the SEC11/27/23